Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Mylan announces FDA's acceptance of ANDA filing for generic Advair Diskus

Mylan N.V. today announced that its abbreviated new drug application (ANDA) for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder has been accepted for filing by the U.S. Food and Drug Administration.

22 Feb 2016

Household and outdoor air pollution kills more than 5.5 million people every year

New research shows that more than 5.5 million people die prematurely every year due to household and outdoor air pollution. More than half of deaths occur in two of the world's fastest growing economies, China and India.

15 Feb 2016

Apellis Pharmaceuticals completes $47.1M Series D preferred stock financing

Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing, co-led by new investors Cormorant Asset Management, Hillhouse Capital Group and venBio Global Strategic Fund, joining existing investors Morningside Venture Investments, AJU IB Investment, and Epidarex Capital.

12 Feb 2016

Patients with COPD show decreased gray matter volume in certain areas of the brain

Chronic Obstructive Pulmonary Disease (COPD), a condition impacting nearly 24 million Americans, is often associated with disease-specific fears and avoidance of physical activity. Little is known of the structural brain processes that occur in COPD patients. A study published in the February issue of the journal CHEST found that patients with COPD demonstrated gray matter decreases in areas of the brain that process breathlessness, fear and sensitivity to pain.

9 Feb 2016

Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

The prevalence of past-year generalized anxiety disorder (GAD) for adults aged 50 and older with chronic obstructive pulmonary disease (COPD) is much higher compared to older adults without COPD (5.8% vs 1.7%), according to a new study published by University of Toronto researchers.

4 Feb 2016

Experts call for new approach to asthma and COPD patient management

Defining a patient's symptoms using the historical diagnostic labels of asthma and chronic obstructive pulmonary disease (COPD) is an outdated approach to understanding an individual's condition, according to experts writing in the European Respiratory Journal today (Feb. 1, 2016).

1 Feb 2016

Involving family members in care may reduce hospital readmissions

A new study finds that educating and involving family members in the care of a loved one who has memory loss may significantly reduce hospital readmissions.

28 Jan 2016

New diagnostic method shows COPD risk higher for women

Researchers from Lund University Sweden have through a new diagnostic method been able to show that the risk of developing Chronic Obstructive Pulmonary Disease could be twice as high for women as it is for men.

19 Jan 2016

GBI Research says COPD therapeutics pipeline lacks innovation

Analysis from business intelligence provider GBI Research - Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation - states that while currently-available drugs aim to manage the frequency and severity of symptoms associated with COPD, none have been shown to modify long-term disease progression.

19 Jan 2016

Specialized oral nutrition supplement associated with 50% lower death rate in older patients

Results from a new clinical trial show that a specialized oral nutrition supplement was associated with a 50 percent lower death rate in older malnourished patients with a heart or lung disease 90 days following hospitalization.

18 Jan 2016

Alignment Healthcare, HCA West Florida partner to better serve Medicare beneficiaries in West Florida

Alignment Healthcare, a company focused on improving the health of the Medicare population, announced that it has joined forces with HCA West Florida to better serve Medicare beneficiaries in three West Florida counties: Manatee, Pinellas and Sarasota.

13 Jan 2016

Malaysian scientists join forces with Harvard experts to help revolutionize lung disease treatment

Malaysian scientists are joining forces with Harvard University experts to help revolutionize the treatment of lung diseases -- the delivery of nanomedicine deep into places otherwise impossible to reach.

12 Jan 2016

Qualcomm Life expands global connected therapy management collaboration with Novartis

Qualcomm Incorporated today announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global connected therapy management collaboration. Novartis will leverage Qualcomm Life's connectivity solutions to power its next-generation connected Breezhaler, the inhaler for its Chronic Obstructive Pulmonary Disease (COPD) portfolio.

6 Jan 2016

Body can control pathogen-induced inflammatory response, find Georgia State researchers

The body can control inflammatory response triggered by invasions of microbial pathogens, such as bacteria and viruses, a discovery that could lead to the development of new therapeutic agents for uncontrolled inflammation, according to researchers at Georgia State University.

29 Dec 2015

Music therapy in conjunction with standard rehabilitation benefits COPD patients

Patients with Chronic Obstructive Pulmonary Disease (COPD) and other chronic respiratory disorders who received music therapy in conjunction with standard rehabilitation saw an improvement in symptoms, psychological well-being and quality of life compared to patients receiving rehabilitation alone, according to a new study by researchers at The Louis Armstrong Center of Music and Medicine at Mount Sinai Beth Israel (MSBI).

24 Dec 2015

Small airway-on-a-chip enables analysis of human COPD and asthma

A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.

22 Dec 2015

IQWiG examines added benefit of tiotropium and olodaterol combination in adults with COPD

The fixed-dose combination of tiotropium and olodaterol (trade name: Spiolto Respimat) has been approved since July 2015 for maintenance treatment in adults with chronic obstructive pulmonary disease (COPD). The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug combination offers an added benefit over the appropriate comparator therapy.

22 Nov 2015

Study finds high prevalence of dehydration in older people living in UK care homes

One in every five older people living in UK care homes has dehydration, suggesting that they are not drinking enough to keep themselves healthy.

11 Nov 2015

Rheumatoid arthritis significantly increases risk of death due to cardiovascular causes

Rheumatoid arthritis (RA) has been associated with increased risk of death in the past, but a new study by investigators from Brigham and Women's Hospital brings that risk into sharper focus. Using data from the Nurses' Health Study, which has followed more than 100,000 female registered nurses since 1976, researchers found that rheumatoid arthritis significantly increased participants' overall risk of death, especially risk of death due to respiratory or cardiovascular causes.

3 Nov 2015

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD.

30 Oct 2015

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Mylan announces FDA's acceptance of ANDA filing for generic Advair Diskus

Household and outdoor air pollution kills more than 5.5 million people every year

Apellis Pharmaceuticals completes $47.1M Series D preferred stock financing

Patients with COPD show decreased gray matter volume in certain areas of the brain

Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

Experts call for new approach to asthma and COPD patient management

Involving family members in care may reduce hospital readmissions

New diagnostic method shows COPD risk higher for women

GBI Research says COPD therapeutics pipeline lacks innovation

Specialized oral nutrition supplement associated with 50% lower death rate in older patients

Alignment Healthcare, HCA West Florida partner to better serve Medicare beneficiaries in West Florida

Malaysian scientists join forces with Harvard experts to help revolutionize lung disease treatment

Qualcomm Life expands global connected therapy management collaboration with Novartis

Body can control pathogen-induced inflammatory response, find Georgia State researchers

Music therapy in conjunction with standard rehabilitation benefits COPD patients

Small airway-on-a-chip enables analysis of human COPD and asthma

IQWiG examines added benefit of tiotropium and olodaterol combination in adults with COPD

Study finds high prevalence of dehydration in older people living in UK care homes

Rheumatoid arthritis significantly increases risk of death due to cardiovascular causes

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in